Researchers Find Promise in New Treatment for Peanut Allergy

Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine have said that an oral immunotherapy drug they tested could be the first FDA-approved medication of its kind for people with peanut allergy. The medication, called AR101, is derived [...]

By |2018-11-21T13:41:37+00:00November 21st, 2018|Regional News|Comments Off on Researchers Find Promise in New Treatment for Peanut Allergy

New Approaches for Treating Psychiatric Disorders

Cardiff University has formed a drug discovery collaboration with Takeda Pharmaceutical Company Limited (Takeda) to identify new approaches for treating schizophrenia and other psychiatric disorders. The collaboration will combine the university’s large-scale genomic data, and world-class expertise in psychiatric genetics, genomics, and neuroscience, with Takeda’s extensive drug discovery and clinical development capabilities. ‘Recent developments in [...]

By |2018-11-21T13:40:27+00:00November 21st, 2018|Regional News|Comments Off on New Approaches for Treating Psychiatric Disorders

New Drug to Treat Travellers’ Diarrhoea

The US Food and Drug Administration (FDA) recently approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travellers’ diarrhoea caused by non-invasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool. ‘Travellers’ diarrhoea affects millions of people each year and having treatment options for [...]

By |2018-11-21T13:38:31+00:00November 21st, 2018|Regional News|Comments Off on New Drug to Treat Travellers’ Diarrhoea